TelyRx Holdings (TSX:TELY) Shares Outstanding (EOP): 26.58 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:TELY TelyRx Holdings Inc TSX:TELY
12 GF Score
Price C$2.60
! 1 Warning Sign
View Full Analysis

What is TelyRx Holdings Shares Outstanding (EOP)?

TelyRx Holdings TSX:TELY +13.04% 12 Shares Outstanding (EOP) is 26.58 Mil as of Mar. 2026. GuruFocus rates TSX:TELY with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. TelyRx Holdings's shares outstanding for the quarter that ended in Mar. 2026 was 26.58 Mil.

TelyRx Holdings's quarterly shares outstanding increased from Dec. 2025 (24.69 Mil) to Mar. 2026 (26.58 Mil). It means TelyRx Holdings issued new shares from Dec. 2025 to Mar. 2026 .

TelyRx Holdings's annual shares outstanding stayed the same from Dec. 2024 (24.69 Mil) to Dec. 2025 (24.69 Mil).


TelyRx Holdings  (TSX:TELY) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


TelyRx Holdings Shares Outstanding (EOP) Related Terms


TelyRx Holdings Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for TelyRx Holdings's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TelyRx Holdings Shares Outstanding (EOP) Chart

TelyRx Holdings Annual Data
Trend Dec23 Dec24 Dec25
Shares Outstanding (EOP)
24.69 24.69 24.69

TelyRx Holdings Quarterly Data
Dec23 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial 24.69 24.69 24.69 24.69 26.58

TelyRx Holdings Shares Outstanding (EOP) Competitor Comparison

For the Pharmaceutical Retailers subindustry, TelyRx Holdings's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TelyRx Holdings Shares Outstanding (EOP) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TelyRx Holdings's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where TelyRx Holdings's Shares Outstanding (EOP) falls into.


TSX:TELY
12GF Score
TelyRx Holdings Inc TSX:TELY
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TelyRx Holdings Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 26.58 Mil mean?
TelyRx Holdings (TSX:TELY) has a Shares Outstanding (EOP) of 26.58 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on TelyRx Holdings and its competitors.
Is TelyRx Holdings' Shares Outstanding (EOP) too high?
TelyRx Holdings' current Shares Outstanding (EOP) is 26.58 Mil. Overall, TelyRx Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TelyRx Holdings' Shares Outstanding (EOP) compare to competitors?
TelyRx Holdings' Shares Outstanding (EOP) of 26.58 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on TelyRx Holdings and its competitors. TelyRx Holdings's current Shares Outstanding (EOP) is 26.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TelyRx Holdings stock overvalued right now?
TelyRx Holdings (TSX:TELY) has a current Shares Outstanding (EOP) of 26.58 Mil. The current Shares Outstanding (EOP) is 26.58 Mil. TelyRx Holdings' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For TelyRx Holdings (TSX:TELY), the current Shares Outstanding (EOP) is 26.58 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TelyRx Holdings Business Description

Address 24761 US Highway 19 North, Clearwater, FL, USA, 33763
TelyRx Holdings Inc is a vertically integrated technology enabled healthcare and pharmacy services provider, operating a digital pharmacy platform that connects patients with independent, state-licensed providers. The TelyRx platform provides the Providers with access to a clinically focused electronic medical records system and the ability for them to electronically prescribe. TelyRx enables patient access to a risk-curated formulary of over 450 noncontrolled, and non-compounded prescription medications selected by the Providers to address a broad cross-section of everyday chronic and acute ailments.
12GF Score

Get the complete analysis for TSX:TELY

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$2.60
Price